Fulcrum Therapeutics Inc (FULC)
7.77
+0.14
(+1.83%)
USD |
NASDAQ |
May 03, 16:00
7.77
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Shareholders Equity (Quarterly): 235.19M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 235.19M |
| September 30, 2023 | 255.46M |
| June 30, 2023 | 275.43M |
| March 31, 2023 | 296.26M |
| December 31, 2022 | 198.94M |
| September 30, 2022 | 221.41M |
| June 30, 2022 | 160.76M |
| March 31, 2022 | 189.16M |
| December 31, 2021 | 211.54M |
| September 30, 2021 | 230.61M |
| June 30, 2021 | 110.89M |
| Date | Value |
|---|---|
| March 31, 2021 | 127.75M |
| December 31, 2020 | 95.18M |
| September 30, 2020 | 104.98M |
| June 30, 2020 | 122.13M |
| March 31, 2020 | 70.63M |
| December 31, 2019 | 87.15M |
| September 30, 2019 | 102.13M |
| June 30, 2019 | 53.46M |
| March 31, 2019 | 65.45M |
| December 31, 2018 | 76.00M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
53.46M
Minimum
Jun 2019
296.26M
Maximum
Mar 2023
165.74M
Average
160.76M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 89.01B |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 39.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 257.69M |
| Total Liabilities (Quarterly) | 22.50M |
| Current Ratio | 17.71 |